Top

Published in:

01-04-2017 | Neuroradiology

Reproducibility of dynamic contrast-enhanced MRI and dynamic susceptibility contrast MRI in the study of brain gliomas: a comparison of data obtained using different commercial software

Authors: Gian Marco Conte, Antonella Castellano, Luisa Altabella, Antonella Iadanza, Marcello Cadioli, Andrea Falini, Nicoletta Anzalone

Published in: La radiologia medica | Issue 4/2017

Abstract

Purpose

Dynamic susceptibility contrast MRI (DSC) and dynamic contrast-enhanced MRI (DCE) are useful tools in the diagnosis and follow-up of brain gliomas; nevertheless, both techniques leave the open issue of data reproducibility. We evaluated the reproducibility of data obtained using two different commercial software for perfusion maps calculation and analysis, as one of the potential sources of variability can be the software itself.

Methods

DSC and DCE analyses from 20 patients with gliomas were tested for both the intrasoftware (as intraobserver and interobserver reproducibility) and the intersoftware reproducibility, as well as the impact of different postprocessing choices [vascular input function (VIF) selection and deconvolution algorithms] on the quantification of perfusion biomarkers plasma volume (Vp), volume transfer constant (K ^trans) and rCBV. Data reproducibility was evaluated with the intraclass correlation coefficient (ICC) and Bland–Altman analysis.

Results

For all the biomarkers, the intra- and interobserver reproducibility resulted in almost perfect agreement in each software, whereas for the intersoftware reproducibility the value ranged from 0.311 to 0.577, suggesting fair to moderate agreement; Bland–Altman analysis showed high dispersion of data, thus confirming these findings. Comparisons of different VIF estimation methods for DCE biomarkers resulted in ICC of 0.636 for K ^trans and 0.662 for Vp; comparison of two deconvolution algorithms in DSC resulted in an ICC of 0.999.

Conclusions

The use of single software ensures very good intraobserver and interobservers reproducibility. Caution should be taken when comparing data obtained using different software or different postprocessing within the same software, as reproducibility is not guaranteed anymore.

Available only for authorised users

Nguyen TB, Cron GO, Perdrizet K et al (2015) Comparison of the diagnostic accuracy of DSC- and dynamic contrast-enhanced MRI in the preoperative grading of astrocytomas. Am J Neuroradiol 36:2017–2022. doi:10.3174/ajnr.a4398 CrossRefPubMed

Emblem K, Nedregaard B, Nome T et al (2008) Glioma grading by using histogram analysis of blood volume heterogeneity from MR-derived cerebral blood volume maps. Radiology 247:808–817. doi:10.1148/radiol.2473070571 CrossRefPubMed

Jung SC, Yeom JA, Kim JH et al (2014) Glioma: application of histogram analysis of pharmacokinetic parameters from T1-weighted dynamic contrast-enhanced MR imaging to tumor grading. Am J Neuroradiol 35:1103–1110. doi:10.3174/ajnr.A3825 CrossRefPubMed

Law M, Yang S, Babb J et al (2004) Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade. AJNR Am J Neuroradiol 25:746–755PubMed

Falk A, Fahlström M, Rostrup E et al (2014) Discrimination between glioma grades II and III in suspected low-grade gliomas using dynamic contrast-enhanced and dynamic susceptibility contrast perfusion MR imaging: a histogram analysis approach. Neuroradiology 56:1031–1038. doi:10.1007/s00234-014-1426-z CrossRefPubMed

Law M, Young R, Babb J et al (2008) Gliomas: predicting time to progression or survival with cerebral blood volume measurements at dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. Radiology 247:490–498. doi:10.1148/radiol.2472070898 CrossRefPubMedPubMedCentral

Schmainda KM, Prah M, Connelly J et al (2014) Dynamic-susceptibility contrast agent MRI measures of relative cerebral blood volume predict response to bevacizumab in recurrent high-grade glioma. Neuro Oncol 16:880–888. doi:10.1093/neuonc/not216 CrossRefPubMedPubMedCentral

Piludu F, Marzi S, Pace A et al (2015) Early biomarkers from dynamic contrast-enhanced magnetic resonance imaging to predict the response to antiangiogenic therapy in high-grade gliomas. Neuroradiology 57:1269–1280. doi:10.1007/s00234-015-1582-9 CrossRefPubMed

Kim R, Choi S, Yun T et al (2016) Prognosis prediction of non-enhancing T2 high signal intensity lesions in glioblastoma patients after standard treatment: application of dynamic contrast-enhanced MR imaging. Eur Radiol. doi:10.1007/s00330-016-4464-6 PubMedCentral

10.

Khalifa J, Tensaouti F, Chaltiel L et al (2016) Identification of a candidate biomarker from perfusion MRI to anticipate glioblastoma progression after chemoradiation. Eur Radiol. doi:10.1007/s00330-016-4234-5 PubMed

11.

Sanz-Requena R, Revert-Ventura A, Martí-Bonmatí L et al (2013) Quantitative MR perfusion parameters related to survival time in high-grade gliomas. Eur Radiol 23:3456–3465. doi:10.1007/s00330-013-2967-y CrossRefPubMed

12.

Yoon R, Kim H, Paik W et al (2016) Different diagnostic values of imaging parameters to predict pseudoprogression in glioblastoma subgroups stratified by MGMT promoter methylation. Eur Radiol. doi:10.1007/s00330-016-4346-y PubMedCentral

13.

Larsen V, Simonsen H, Law I et al (2012) Evaluation of dynamic contrast-enhanced T1-weighted perfusion MRI in the differentiation of tumor recurrence from radiation necrosis. Neuroradiology 55:361–369. doi:10.1007/s00234-012-1127-4 CrossRefPubMed

14.

Wang S, Martinez-Lage M, Sakai Y et al (2015) Differentiating tumor progression from pseudoprogression in patients with glioblastomas using diffusion tensor imaging and dynamic susceptibility contrast MRI. Am J Neuroradiol 37:28–36. doi:10.3174/ajnr.A4474 CrossRefPubMed

15.

Thomas AA, Arevalo-Perez J, Kaley T et al (2015) Dynamic contrast enhanced T1 MRI perfusion differentiates pseudoprogression from recurrent glioblastoma. J Neurooncol 125:183–190. doi:10.1007/s11060-015-1893-z CrossRefPubMedPubMedCentral

16.

Prager AJ, Martinez N, Beal K et al (2015) Diffusion and perfusion MRI to differentiate treatment-related changes including pseudoprogression from recurrent tumors in high-grade gliomas with histopathologic evidence. Am J Neuroradiol 36:877–885. doi:10.3174/ajnr.A4218 CrossRefPubMedPubMedCentral

17.

Heye AK, Culling RD, Hernández MDCV et al (2014) Assessment of blood-brain barrier disruption using dynamic contrast-enhanced MRI. a systematic review. Neuroimage Clin 6:262–274. doi:10.1016/j.nicl.2014.09.002 CrossRefPubMedPubMedCentral

18.

Ellingson B, Bendszus M, Sorensen G, Pope W (2014) Emerging techniques and technologies in brain tumor imaging. Neuro Oncol 16:vii12–vii23. doi:10.1093/neuonc/nou221 CrossRefPubMedPubMedCentral

19.

Shiroishi M, Boxerman J, Pope W (2015) Physiologic MRI for assessment of response to therapy and prognosis in glioblastoma. Neuro Oncol. doi:10.1093/neuonc/nov179 PubMed

20.

Usinskiene J, Ulyte A, Bjørnerud A et al (2016) Optimal differentiation of high- and low-grade glioma and metastasis: a meta-analysis of perfusion, diffusion, and spectroscopy metrics. Neuroradiology. doi:10.1007/s00234-016-1642-9 PubMedCentral

21.

Goh V, Schaeffter T, Leach M (2013) Reproducibility of dynamic contrast-enhanced MR imaging: why we should care. Radiology. doi:10.1148/radiol.12122447

22.

Viallon M, Cuvinciuc V, Delattre B et al (2015) State-of-the-art MRI techniques in neuroradiology: principles, pitfalls, and clinical applications. Neuroradiology 57:441–467. doi:10.1007/s00234-015-1500-1 CrossRefPubMed

23.

DCE-MRI Technical Committee (2012) DCE-MRI quantification profile, quantitative imaging biomarkers alliance. Version 1.0. Publicly Reviewed Version. QIBA. http://RSNA.org/QIBA

24.

Welker K, Boxerman J, Kalnin A et al (2015) ASFNR recommendations for clinical performance of MR dynamic susceptibility contrast perfusion imaging of the brain. AJNR Am J Neuroradiol 36:E41–E51. doi:10.3174/ajnr.A4341 CrossRefPubMedPubMedCentral

25.

Heye T, Davenport M, Horvath J et al (2013) Reproducibility of dynamic contrast-enhanced MR imaging. Part I. Perfusion characteristics in the female pelvis by using multiple computer-aided diagnosis perfusion analysis solutions. Radiology 266:801–811. doi:10.1148/radiol.12120278 CrossRefPubMed

26.

Orsingher L, Piccinini S, Crisi G (2014) Differences in dynamic susceptibility contrast MR perfusion maps generated by different methods implemented in commercial software. J Comput Assist Tomogr 38:647–654. doi:10.1097/RCT.0000000000000115 CrossRefPubMed

27.

Kudo K, Sasaki M, Yamada K et al (2010) Differences in CT perfusion maps generated by different commercial software: quantitative analysis by using identical source data of acute stroke patients1. Radiology. doi:10.1148/radiol.254082000

28.

Beuzit L, Eliat P-AA, Brun V et al (2015) Dynamic contrast-enhanced MRI: study of inter-software accuracy and reproducibility using simulated and clinical data. J Magn Reson Imaging. doi:10.1002/jmri.25101 PubMed

29.

Goh V, Shastry M, Engledow A et al (2010) Commercial software upgrades may significantly alter perfusion CT parameter values in colorectal cancer. Eur Radiol 21:744–749. doi:10.1007/s00330-010-1967-4 CrossRefPubMed

30.

Kudo K, Christensen S, Sasaki M et al (2013) Accuracy and reliability assessment of CT and MR perfusion analysis software using a digital phantom. Radiology 267:201–211. doi:10.1148/radiol.12112618 CrossRefPubMedPubMedCentral

31.

Milchenko M, Rajderkar D, LaMontagne P et al (2014) Comparison of perfusion- and diffusion-weighted imaging parameters in brain tumor studies processed using different software platforms. Acad Radiol 21:1294–1303. doi:10.1016/j.acra.2014.05.016 CrossRefPubMedPubMedCentral

32.

Kelm ZS, Korfiatis PD, Lingineni RK, Daniels JR, Buckner JC, Lachance DH, Parney IF, Carter RE, Erickson BJ (2015) Variability and accuracy of different software packages for dynamic susceptibility contrast magnetic resonance imaging for distinguishing glioblastoma progression from pseudoprogression. J Med Imaging (Bellingham) 2(2):026001CrossRef

33.

Tofts PS, Brix G, Buckley DL et al (1999) Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging 10:223–232CrossRefPubMed

34.

Mouridsen K, Christensen S, Gyldensted L, Østergaard L (2006) Automatic selection of arterial input function using cluster analysis. Magn Reson Med 55:524–531. doi:10.1002/mrm.20759 CrossRefPubMed

35.

Østergaard L, Sorensen A, Kwong K et al (1996) High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part II: experimental comparison and preliminary results. Magnet Reson Med 36:726–736. doi:10.1002/mrm.1910360511 CrossRef

36.

Wu O, Østergaard L, Weisskoff RM et al (2003) Tracer arrival timing-insensitive technique for estimating flow in MR perfusion-weighted imaging using singular value decomposition with a block-circulant deconvolution matrix. Magn Reson Med 50:164–174. doi:10.1002/mrm.10522 CrossRefPubMed

Title: Reproducibility of dynamic contrast-enhanced MRI and dynamic susceptibility contrast MRI in the study of brain gliomas: a comparison of data obtained using different commercial software
Authors: Gian Marco Conte
Antonella Castellano
Luisa Altabella
Antonella Iadanza
Marcello Cadioli
Andrea Falini
Nicoletta Anzalone
Publication date: 01-04-2017
Publisher: Springer Milan
Published in: La radiologia medica / Issue 4/2017
Print ISSN: 0033-8362
Electronic ISSN: 1826-6983
DOI: https://doi.org/10.1007/s11547-016-0720-8

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Reproducibility of dynamic contrast-enhanced MRI and dynamic susceptibility contrast MRI in the study of brain gliomas: a comparison of data obtained using different commercial software

Abstract

Purpose

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 4/2017

Multidetector CT findings of histopathologically proven peritoneal tuberculous cold abscesses

A critical appraisal of endovascular stent-grafts in the management of abdominal aortic aneurysms

Noise-optimized monoenergetic post-processing improves visualization of incidental pulmonary embolism in cancer patients undergoing single-pass dual-energy computed tomography

Clinical and magnetic resonance evolution of “infarct-like” myocarditis

Late toxicity, evolving radiotherapy techniques, and quality of life in nasopharyngeal carcinoma

Bronchial artery embolization for the treatment of haemoptysis in pulmonary hypertension